Evidence map›Paper›PMID 38291443›Full record

ArticleBMC health services research2024

Integrating accompanying patients into clinical oncology teams: limiting and facilitating factors.

Marie-Pascale Pomey, Jesseca Paquette, Monica Iliescu Nelea, Cécile Vialaron, Rim Mourad, Karine Bouchard, Louise Normandin, Marie-Andrée Côté, Mado Desforges, Pénélope Pomey-Carpentier and 15 more

Abstract read
In one paragraph

Article in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Marie-Pascale PomeyResearch Centre of the University of Montreal Hospital Centre, Montréal, QC, Canada. marie-pascale.pomey@umontreal.ca.
Jesseca PaquetteResearch Centre of the University of Montreal Hospital Centre, Montréal, QC, Canada.
Monica Iliescu NeleaResearch Centre of the University of Montreal Hospital Centre, Montréal, QC, Canada.
Cécile VialaronResearch Centre of the University of Montreal Hospital Centre, Montréal, QC, Canada.
Rim MouradResearch Centre of the University of Montreal Hospital Centre, Montréal, QC, Canada.
Karine BouchardCentre Hospitalier Universitaire- CHU de Québec-Université Laval, Québec, QC, Canada.
Louise NormandinResearch Centre of the University of Montreal Hospital Centre, Montréal, QC, Canada.
Marie-Andrée CôtéResearch Centre of the University of Montreal Hospital Centre, Montréal, QC, Canada.
Mado DesforgesResearch Centre of the University of Montreal Hospital Centre, Montréal, QC, Canada.
Pénélope Pomey-CarpentierResearch Centre of the University of Montreal Hospital Centre, Montréal, QC, Canada.
Israël FortinCentre Intégré, Universitaire de Santé Et Services Sociaux de L'Est-de-L'Île-de Montréal, Hôpital de Maisonneuve-Rosemont, Montréal, QC, Canada.
Isabelle GanacheInstitut National d'excellence en Santé Et Services Sociaux (INESSS), Montréal, QC, Canada.
Catherine RégisUniversité de Montréal - Faculté de droit, Montréal, QC, Canada.
Zeev RosbergerGerald Bronfman Department of Oncology, Lady Davis Institute for Medical Research, Jewish General Hospital &, McGill University, Montréal, QC, Canada.
Danielle CharpentierCentre Hospitalier Universitaire de Montréal (CHUM), Montréal, QC, Canada.
Marie-France VachonCentre Hospitalier Universitaire de Montréal (CHUM), Montréal, QC, Canada.
Lynda BélangerCentre Hospitalier Universitaire- CHU de Québec-Université Laval, Québec, QC, Canada.
Michel DorvalFaculté de Pharmacie, Université Laval, Québec, QC, Canada.
Djahanchah P GhadiriDepartment of Management, HEC Montréal, Montréal, QC, Canada.
Mélanie Lavoie-TremblayFaculté Des Sciences Infirmières, Université de Montréal, Montréal, QC, Canada.
Antoine BoivinResearch Centre of the University of Montreal Hospital Centre, Montréal, QC, Canada.
Jean-François PelletierCentre Intégré de Santé Et de Services Sociaux de La Montérégie-Ouest, St-Hubert, QC, Canada.
Nicolas FernandezDepartment of Family and Emergency Medicine, Faculté de Médecine, Université de Montréal, Montréal, QC, Canada.
Alain M DaninoResearch Centre of the University of Montreal Hospital Centre, Montréal, QC, Canada.
Michèle de GuiseInstitut National d'excellence en Santé Et Services Sociaux (INESSS), Montréal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSince 2018, four establishments in Quebec have been instrumental in implementing the PAROLE-Onco program, which introduced accompanying patients (APs) into healthcare teams to improve cancer patients' experience. APs are patient advisors who have acquired specific experiential knowledge related to living with cancer, using services, and interacting with healthcare professionals. They are therefore in a unique and reliable position to be able to provide emotional, informational, cognitive and navigational support to patients who are dealing with cancer. We aimed to explore APs' perspectives regarding the limiting and facilitating factors in terms of how they are integrated into the clinical oncology teams.

methodsA qualitative study based on semi-structured interviews and focus groups was conducted with 20 APs at the beginning of their intervention (T1) and, two years later, during a second data collection (T2). Limiting and facilitating factors of APs' integration into clinical teams were analyzed in terms of governance, culture, resources and tools.

resultsThe limited factors raised by APs to be integrated into clinical teams include the following: confusion about the specific roles played by APs, lifting the egos of certain professionals who feel they are already doing what APs typically do, lack of identification of patient needs, absence of APs in project governance organizational boundaries, and team members' availability. Various communication challenges were also raised, resulting in the program being inadequately promoted among patients. Also mentioned as limiting factors were the lack of time, space and compensation. Creating opportunities for team members to meet with APs, building trust and teaching team members how APs' activities complement theirs were enhancing factors. Other facilitators include APs being involved in decision-making committees, being leaders in promoting the PAROLE-Onco program to patients and clinical team members and creating opportunities to communicate with team members to help enhance their work and provide feedback to improve patient services. Awareness of APs' added value for the team and patients is also a key facilitator. Regarding tools, offering accompanying services by telephone allows both patients and APs to benefit from the flexibility they need.

conclusionOver time, APs were able to identify optimal factors for successful implementation. Recommendations include APs and professionals working in co-construction on organization, leadership, resources and status factors. This could help catalyze a change in culture within health establishments and allow people dealing with cancer to benefit from the experiential knowledge of other patients within their clinical team.

Indexed as

Health PersonnelNeoplasmsFocus GroupsHumansMedical OncologyQualitative ResearchAccompanying patientsBarriersClinical teamFacilitating factorsOncologyPatient advisorPatient care experiencePeer support

Identifiers

PMID38291443
PMCPMC10826234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.